Covered recipient · General Payments record
TESSA KAYE MORRISON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,665.61
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $274.59 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Vanda Pharmaceuticals Inc. | $53.99 | 1 |
| Xeris Pharmaceuticals, Inc. | $39.89 | 2 |
| ABBVIE INC. | $39.24 | 2 |
| Acerta Pharma LLC | $27.62 | 2 |
| DEXCOM, INC. | $23.36 | 1 |
| GlaxoSmithKline, LLC. | $19.74 | 1 |
| PFIZER INC. | $18.59 | 1 |
| Novo Nordisk AS | $18.05 | 1 |
| Exact Sciences Corporation | $17.37 | 1 |
| Lilly USA, LLC | $16.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.61 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107697590 | CMS |
| ABBVIE INC. | $24.63 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107697592 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.86 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105882126 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.76 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105643674 | CMS |
| Dexcom, Inc. | $23.36 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153389528 | CMS |
| Exact Sciences Corporation | $17.37 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114487177 | CMS |
| GlaxoSmithKline, LLC. | $19.74 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116422943 | CMS |
| Lilly USA, LLC | $16.74 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135969074 | CMS |
| Novo Nordisk Inc | $18.05 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100608074 | CMS |
| PFIZER INC. | $18.59 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131225258 | CMS |
| Vanda Pharmaceuticals Inc. | $53.99 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133959796 | CMS |
| Xeris Pharmaceuticals, Inc. | $22.58 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144639924 | CMS |
| Xeris Pharmaceuticals, Inc. | $17.31 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144639926 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.